NDC properties for NDC 9 16571-140
NDC item 16571014010
NDC 9 | 16571-140 |
---|---|
NDC 10 | 16571-140-10 |
NDC Item | 16571014010 |
packaging | 1 BOTTLE in 1 CARTON (16571-140-10) / 10 mL in 1 BOTTLE |
ANDA | ANDA077259 |
Labeler | Rising Pharma Holdings, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing status | COMPLETED |
NDC item 16571014015
NDC 9 | 16571-140 |
---|---|
NDC 10 | 16571-140-15 |
NDC Item | 16571014015 |
packaging | 1 BOTTLE in 1 CARTON (16571-140-15) / 15 mL in 1 BOTTLE |
ANDA | ANDA077259 |
Labeler | Rising Pharma Holdings, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing status | COMPLETED |
NDC item 16571014050
NDC 9 | 16571-140 |
---|---|
NDC 10 | 16571-140-50 |
NDC Item | 16571014050 |
packaging | 1 BOTTLE in 1 CARTON (16571-140-50) / 5 mL in 1 BOTTLE |
ANDA | ANDA077259 |
Labeler | Rising Pharma Holdings, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing status | COMPLETED |
NDC item 42571040321
NDC 9 | 42571-403 |
---|---|
NDC 10 | 42571-403-21 |
NDC Item | 42571040321 |
packaging | 5 mL in 1 BOTTLE (42571-403-21) |
ANDA | ANDA217343 |
FDA SPL set id | 813651 |
Labeler | Micro Labs Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-08-01 |
Marketing status | ACTIVE |
NDC item 42571040388
NDC 9 | 42571-403 |
---|---|
NDC 10 | 42571-403-88 |
NDC Item | 42571040388 |
packaging | 10 mL in 1 BOTTLE (42571-403-88) |
ANDA | ANDA217343 |
FDA SPL set id | 813651 |
Labeler | Micro Labs Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-08-01 |
Marketing status | ACTIVE |
NDC item 55545100001
NDC 9 | 55545-1000 |
---|---|
NDC 10 | 55545-1000-1 |
NDC Item | 55545100001 |
packaging | 1 BOTTLE in 1 CARTON (55545-1000-1) / 5 mL in 1 BOTTLE |
ANDA | ANDA077259 |
APPROVED_DRUG_PRODUCT_MANUFACTURED_UNDER_CONTRACT | ANDA077259 |
FDA SPL set id | 281715 |
Labeler | FDC Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | APPROVED DRUG PRODUCT MANUFACTURED UNDER CONTRACT |
Marketing effective time low | 2014-12-15 |
Marketing status | ACTIVE |
NDC item 55545100002
NDC 9 | 55545-1000 |
---|---|
NDC 10 | 55545-1000-2 |
NDC Item | 55545100002 |
packaging | 1 BOTTLE in 1 CARTON (55545-1000-2) / 10 mL in 1 BOTTLE |
ANDA | ANDA077259 |
APPROVED_DRUG_PRODUCT_MANUFACTURED_UNDER_CONTRACT | ANDA077259 |
FDA SPL set id | 281715 |
Labeler | FDC Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | APPROVED DRUG PRODUCT MANUFACTURED UNDER CONTRACT |
Marketing effective time low | 2014-12-15 |
Marketing status | ACTIVE |
NDC item 55545100003
NDC 9 | 55545-1000 |
---|---|
NDC 10 | 55545-1000-3 |
NDC Item | 55545100003 |
packaging | 1 BOTTLE in 1 CARTON (55545-1000-3) / 15 mL in 1 BOTTLE |
ANDA | ANDA077259 |
APPROVED_DRUG_PRODUCT_MANUFACTURED_UNDER_CONTRACT | ANDA077259 |
FDA SPL set id | 281715 |
Labeler | FDC Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | APPROVED DRUG PRODUCT MANUFACTURED UNDER CONTRACT |
Marketing effective time low | 2014-12-15 |
Marketing status | ACTIVE |
NDC item 60758080205
NDC 9 | 60758-802 |
---|---|
NDC 10 | 60758-802-05 |
NDC Item | 60758080205 |
packaging | 1 BOTTLE, DROPPER in 1 CARTON (60758-802-05) / 5 mL in 1 BOTTLE, DROPPER |
ANDA | ANDA074746 |
COLORTEXT | white(clear/ light yellow) |
Color | C48325 __ |
FDA SPL set id | 600609 |
Labeler | Pacific Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1997-05-20 |
Marketing status | ACTIVE |
NDC item 60758080210
NDC 9 | 60758-802 |
---|---|
NDC 10 | 60758-802-10 |
NDC Item | 60758080210 |
packaging | 1 BOTTLE, DROPPER in 1 CARTON (60758-802-10) / 10 mL in 1 BOTTLE, DROPPER |
ANDA | ANDA074746 |
COLORTEXT | white(clear/ light yellow) |
Color | C48325 __ |
FDA SPL set id | 600609 |
Labeler | Pacific Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1997-05-20 |
Marketing status | ACTIVE |
NDC item 61314022605
NDC 9 | 61314-226 |
---|---|
NDC 10 | 61314-226-05 |
NDC Item | 61314022605 |
packaging | 5 mL in 1 BOTTLE, PLASTIC (61314-226-05) |
ANDA | ANDA074261 |
FDA SPL set id | 804173 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1996-01-15 |
Marketing status | ACTIVE |
NDC item 61314022610
NDC 9 | 61314-226 |
---|---|
NDC 10 | 61314-226-10 |
NDC Item | 61314022610 |
packaging | 10 mL in 1 BOTTLE, PLASTIC (61314-226-10) |
ANDA | ANDA074261 |
FDA SPL set id | 804173 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1996-01-15 |
Marketing status | ACTIVE |
NDC item 61314022615
NDC 9 | 61314-226 |
---|---|
NDC 10 | 61314-226-15 |
NDC Item | 61314022615 |
packaging | 15 mL in 1 BOTTLE, PLASTIC (61314-226-15) |
ANDA | ANDA074261 |
FDA SPL set id | 804173 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1996-01-15 |
Marketing status | ACTIVE |
NDC item 64980051301
NDC 9 | 64980-513 |
---|---|
NDC 10 | 64980-513-01 |
NDC Item | 64980051301 |
packaging | 1 BOTTLE in 1 CARTON (64980-513-01) / 10 mL in 1 BOTTLE |
ANDA | ANDA077259 |
FDA SPL set id | 804336 |
Labeler | Rising Pharma Holdings, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-12-15 |
Marketing status | ACTIVE |
NDC item 64980051305
NDC 9 | 64980-513 |
---|---|
NDC 10 | 64980-513-05 |
NDC Item | 64980051305 |
packaging | 1 BOTTLE in 1 CARTON (64980-513-05) / 5 mL in 1 BOTTLE |
ANDA | ANDA077259 |
FDA SPL set id | 804336 |
Labeler | Rising Pharma Holdings, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-12-15 |
Marketing status | ACTIVE |
NDC item 64980051315
NDC 9 | 64980-513 |
---|---|
NDC 10 | 64980-513-15 |
NDC Item | 64980051315 |
packaging | 1 BOTTLE in 1 CARTON (64980-513-15) / 15 mL in 1 BOTTLE |
ANDA | ANDA077259 |
FDA SPL set id | 804336 |
Labeler | Rising Pharma Holdings, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-12-15 |
Marketing status | ACTIVE |
NDC item 68682081205
NDC 9 | 68682-812 |
---|---|
NDC 10 | 68682-812-05 |
NDC Item | 68682081205 |
packaging | 1 BOTTLE, DISPENSING in 1 CARTON (68682-812-05) / 5 mL in 1 BOTTLE, DISPENSING |
FDA SPL set id | 657377 |
Labeler | Oceanside Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time low | 2020-06-01 |
Marketing status | ACTIVE |
NDA_AUTHORIZED_GENERIC | NDA018086 |
NDC item 70069070101
NDC 9 | 70069-701 |
---|---|
NDC 10 | 70069-701-01 |
NDC Item | 70069070101 |
packaging | 1 BOTTLE in 1 CARTON (70069-701-01) / 5 mL in 1 BOTTLE |
ANDA | ANDA217764 |
FDA SPL set id | 795204 |
Labeler | Somerset Therapeutics, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-07-04 |
Marketing status | ACTIVE |
NDC item 70069070201
NDC 9 | 70069-702 |
---|---|
NDC 10 | 70069-702-01 |
NDC Item | 70069070201 |
packaging | 1 BOTTLE in 1 CARTON (70069-702-01) / 10 mL in 1 BOTTLE |
ANDA | ANDA217764 |
FDA SPL set id | 795204 |
Labeler | Somerset Therapeutics, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-07-04 |
Marketing status | ACTIVE |
NDC item 70069070301
NDC 9 | 70069-703 |
---|---|
NDC 10 | 70069-703-01 |
NDC Item | 70069070301 |
packaging | 1 BOTTLE in 1 CARTON (70069-703-01) / 15 mL in 1 BOTTLE |
ANDA | ANDA217764 |
FDA SPL set id | 795204 |
Labeler | Somerset Therapeutics, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-07-04 |
Marketing status | ACTIVE |
NDC item 70756065415
NDC 9 | 70756-654 |
---|---|
NDC 10 | 70756-654-15 |
NDC Item | 70756065415 |
packaging | 1 BOTTLE, DROPPER in 1 CARTON (70756-654-15) / 5 mL in 1 BOTTLE, DROPPER |
ANDA | ANDA078771 |
FDA SPL set id | 717503 |
Labeler | Lifestar Pharma LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-06-26 |
Marketing status | ACTIVE |
NDC item 70756065530
NDC 9 | 70756-655 |
---|---|
NDC 10 | 70756-655-30 |
NDC Item | 70756065530 |
packaging | 1 BOTTLE, DROPPER in 1 CARTON (70756-655-30) / 10 mL in 1 BOTTLE, DROPPER |
ANDA | ANDA078771 |
FDA SPL set id | 717503 |
Labeler | Lifestar Pharma LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-06-26 |
Marketing status | ACTIVE |
NDC item 81469020905
NDC 9 | 81469-209 |
---|---|
NDC 10 | 81469-209-05 |
NDC Item | 81469020905 |
packaging | 1 BOTTLE, DROPPER in 1 CARTON (81469-209-05) / 5 mL in 1 BOTTLE, DROPPER |
ANDA | ANDA078771 |
FDA SPL set id | 785224 |
Labeler | First Nation Group, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-05-10 |
Marketing status | ACTIVE |
NDC item 81469020910
NDC 9 | 81469-209 |
---|---|
NDC 10 | 81469-209-10 |
NDC Item | 81469020910 |
packaging | 1 BOTTLE, DROPPER in 1 CARTON (81469-209-10) / 10 mL in 1 BOTTLE, DROPPER |
ANDA | ANDA078771 |
FDA SPL set id | 785224 |
Labeler | First Nation Group, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-05-10 |
Marketing status | ACTIVE |
NDC item 82260081205
NDC 9 | 82260-812 |
---|---|
NDC 10 | 82260-812-05 |
NDC Item | 82260081205 |
packaging | 1 BOTTLE, DISPENSING in 1 CARTON (82260-812-05) / 5 mL in 1 BOTTLE, DISPENSING |
FDA SPL set id | 863431 |
Labeler | Bausch & Lomb Americas Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time low | 2020-06-01 |
Marketing status | ACTIVE |
NDA_AUTHORIZED_GENERIC | NDA018086 |